Sun Pharma
-
Sun Pharma scores US FDA authorization to market generic lenalidomide capsules
INDIA – The United States Food and Drug Administration (USFDA) has granted approval to Sun Pharma’s generic medication indicated for several hematological malignancies in adults.…
-
Sun Pharma expands its anti-inflammatory portfolio, acquires Aksigen’s key brands
INDIA – Sun Pharma has reached an agreement with Aksigen Hospital Care to acquire three of its anti-inflammatory brands: ‘Disperzyme’, ‘Disperzyme-CD’, and ‘Phlogam’. The three…
-
Sun Pharma unveils its novel injection for neonatal seizures in the US
INDIA – Sun Pharma has launched its phenobarbital sodium injection for the treatment of neonatal seizures, SEZABY, in the United States (US). The Mumbai-based multinational…
-
Sun Pharma to acquire biotech company Concert for up to US$576M
INDIA – Sun Pharmaceutical Industries Limited (Sun Pharma) has signed a definitive agreement to acquire Concert Pharmaceuticals Inc. (Concert) for up to US$576 million in…
-
Sun Pharma introduces novel anti-cancer drug, FDA issues warning letter to its Halol plant
INDIA – Sun Pharmaceutical Industries Limited (Sun Pharma) has expanded its product portfolio with the launch of its novel anti-cancer drug Palbociclib under brand name…
-
Sun Pharma acquires Uractiv portfolio in Romania
ROMANIA – S C Terapia, a subsidiary of Sun Pharmaceuticals, has announced the acquisition of Fiterman Pharma’s Uractiv portfolio in Romania. According to the company,…
-
Sun Pharma to launch Brillo, a first in class oral lipid lowering drug
INDIA – Sun Pharmaceutical Industries intends to launch Bempedoic Acid, a first-in-class lipid-lowering oral drug that aids in the reduction of low-density lipoprotein (LDL) cholesterol,…
-
Sun Pharma enters licensing pact with Lundbeck to unveil novel anti-depressant pill in India
INDIA – Sun Pharma announced that it has entered into a unique patent licensing agreement with Danish drugmaker Lundbeck to market and distribute its own…
-
Sun Pharma to acquire 11.28% stake in Zenotech from Daiichi Sankyo
INDIA – Sun Pharmaceutical Industries announced on Monday that it has entered into a share purchase agreement with Daiichi Sankyo Company of Japan to acquire…
-
Sun Pharma plans in-licensing and buyouts to expand specialty business portfolio
INDIA – Sun Pharma, India’s giant drugmaker, the company is looking for possible in-licensing opportunities and even acquisitions to bolster its global specialty business, Economic…